Fujifilm Diosynth Biotechnologies Doubles Laboratory Footprint in North Carolina

Expands the sites’ process development, process characterization and analytical services and adds approximately 145 positions by 2024.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and viral gene therapies, is expanding its BioProcess Innovation Center (BIC) in Research Triangle Park (RTP). Through the expansion, Fujifilm Diosynth Biotechnologies will add approximately 145 skilled positions including researchers and scientists to the RTP site by 2024.   The expansion will double Fujifilm Diosynt...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters